Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiforme

Cell Death and Disease

Volumn 1, Issue 1, 2010, Pages

  Hervouet, E ^a,b   Vallette, F M ^a,b   Cartron, P F ^a,b  

^a Team 12   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

apoptosis; Cancer; DNA methylation; Dnmt; GBM; glioma

Indexed keywords

CASPASE 8; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; SURVIVIN; BIRC5 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; INHIBITOR OF APOPTOSIS PROTEIN; PYCARD PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR PROTEIN; XAF1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; DNA METHYLATION; GENE; GENE CONTROL; GLIOBLASTOMA; HRK GENE; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TMS1 GENE; XAF 1 GENE; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 8; CYTOSKELETAL PROTEINS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; GLIOBLASTOMA; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 79953067256     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2009.7     Document Type: Article

References (38)

1. Hanahan D, Weinberg R. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
2. Gopisetty G, Ramachandran K, Singal R. DNA methylation and apoptosis. Mol Immunol 2006; 43: 1729-1740.
3. Estève P, Chin H, Pradhan S. Molecular mechanisms of transactivation and doxorubicinmediated repression of survivin gene in cancer cells. J Biol Chem 2007; 282: 2616-2625.
4. Wang S, Liu N, Wang J, Bai H, Mao L. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer. Chin Med J 2008; 121: 1712-1721.
5. Hervouet E, Debien E, Charbord J, Menanteau J, Vallette FM, Cartron PF. Folate supplementation: a tool to limit the aggressiveness of gliomas via the re-methylation of DNA repeat element and genes governing apoptosis and proliferation. Clin Cancer Res 2009; 15: 3519-3529.
6. Zukiel R, Nowak S, Barciszewska A, Gawronska I, Keith G, Barciszewska M. A simple epigenetic method for the diagnosis and classification of brain tumors. Mol Cancer Res 2004; 2: 196-202. (Pubitemid 39030309)
7. Cartron PF, Oliver L, Martin S, Moreau C, LeCabellec MT, Jezequel P et al. The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum Mol Genet 2002; 11: 675-687. (Pubitemid 34285139)
8. Cartron PF, Juin P, Oliver L, Martin S, Meflah K, Vallette F. Nonredundant role of Bax and Bak in Bid-mediated apoptosis. Mol Cell Biol 2003; 23: 4701-4712. (Pubitemid 36734757)
9. Martinez R, Setien F, Voelter C, Casado S, Quesada M, Schackert G et al. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 2007; 28: 1264-1268. (Pubitemid 47062686)
10. Gao Y, Guan M, Su B, Liu W, Xu M, Lu Y. Hypermethylation of the RASSF1A gene in gliomas. Clin Chim Acta 2004; 349: 173-179. (Pubitemid 39312003)
11. Yu J, Zhang H, Gu J, Lin S, Li J, Lu W et al. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer 2004; 4: 65.
12. Stone A, Bobo W, Brat D, Devi N, Van Meir E, Vertino P. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Am J Pathol 2004; 165: 1151-1161. (Pubitemid 39297722)
13. Nakamura M, Ishida E, Shimada K, Nakase H, Sakaki T, Konishi N. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas. Acta Neuropathol 2005; 110: 402-410. (Pubitemid 41672185)
14. McConnell B, Vertino P. TMS1/ASC: the cancer connection. Apoptosis 2004; 9: 5-18. (Pubitemid 38270424)
15. Juin P, Cartron P, Vallette F. Activation of Bax by BH3 domains during apoptosis: the unfolding of a deadly plot. Cell Cycle 2005; 4: 637-642. (Pubitemid 41353840)
16. Inohara N, Ding L, Chen S, Núñez G. Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J 1997; 16: 1686-1694. (Pubitemid 27151963)
17. Lalier L, Cartron P, Juin P, Nedelkina S, Manon S, Bechinger B et al. Bax activation and mitochondrial insertion during apoptosis. Apoptosis 2007; 12: 887-896. (Pubitemid 46653297)
18. Shin S, Sung B, Cho Y, Kim H, Ha N, Hwang J et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001; 40: 1117-1123. (Pubitemid 32108606)
19. Liston P, Fong W, Kelly N, Toji S, Miyazaki T, Conte D et al. Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 2001; 3: 128-133. (Pubitemid 32118365)
20. Li L, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-1431. (Pubitemid 35414532)
21. Estève P, Chin H, Pradhan S. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci USA 2005; 102: 1000-1005.
22. Fatemi M, Hermann A, Gowher H, Jeltsch A. Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur J Biochem 2002; 269: 4981-4984. (Pubitemid 35279011)
23. Liang G, Chan M, Tomigahara Y, Tsai Y, Gonzales F, Li E et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol Cell Biol 2002; 22: 480-491. (Pubitemid 34027493)
24. Kim G, Ni J, Kelesoglu N, Roberts R, Pradhan S. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J 2002; 21: 4183-4195. (Pubitemid 34857450)
25. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416: 552-556. (Pubitemid 34288859)
26. Sun L, Huang L, Nguyen P, Bisht K, Bar-Sela G, Ho A et al. DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation. Cancer Res 2008; 68: 2726-2735. (Pubitemid 351556270)
27. Sowiñska A, Jagodzinski P. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines. Cancer Lett 2007; 255: 153-159. (Pubitemid 47212611)
28. Stimson K, Vertino P. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. J Biol Chem 2002; 277: 4951-4958. (Pubitemid 34968533)
29. Deplus R, Brenner C, Burgers WA, Putmans P, Kouzarides T, de Launoit Y et al. Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res 2002; 30: 3831-3838. (Pubitemid 35012455)
30. Conway K, McConnell B, Bowring C, Donald C, Warren S, Vertino P. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 2000; 60: 6236-6242.
31. Babidge W, Butler L, Burton M, Cowled P. Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma. Anticancer Res 2001; 21: 2809-2814. (Pubitemid 33054460)
32. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820-1828. (Pubitemid 23278773)
33. Zou B, Chim C, Zeng H, Leung S, Yang Y, Tu S et al. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 2006; 131: 1835-1843. (Pubitemid 44958519)
34. Kempkensteffen C, Hinz S, Schrader M, Christoph F, Magheli A, Krause H et al. Gene expression and promoter methylation of the XIAP-associated factor 1 in renal cell carcinomas: correlations with pathology and outcome. Cancer Lett 2007; 254: 227-235. (Pubitemid 47135616)
35. Byun D, Cho K, Ryu B, Lee M, Kang M, Kim H et al. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res 2003; 63: 7068-7075. (Pubitemid 37413441)
36. Fong W, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk R. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 2000; 70: 113-122.
37. Juin P, Pelletier M, Oliver L, Tremblais K, Grégoire M, Meflah K et al. Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem 1998; 273: 17559-17564.
38. Li LC, Dahiya R. Methprimer: designing primers for methylation PCRs. Bioinformatics 2002; 11: 1427-1431. (Pubitemid 35414532)